The MOMI-VAX study tracked the impact of mRNA vaccines and boosters on pregnant people and their infants.

Friday, August 11, 2023 COVID-19 Vaccination and Boosting During Pregnancy Benefits Pregnant People and Newborns Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, a NIAID-supported study has found. The Multisite Observational Maternal and Infant Study for COVID-19 (MOMI-VAX) tracked the antibodies in blood samples taken from pregnant people both before and after receiving mRNA vaccines and boosters for COVID-19, as well as in their cord blood upon giving birth. Not only did vaccinating and boosting increase levels of antibodies for COVID-19 in pregnant people, but the antibodies crossed the placenta, suggesting that the newborns could also have received some protection against COVID-19. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107